20th Apr 2006 16:30
AstraZeneca PLC20 April 2006 Companies Act 1985 Section 198 Disclosure of Interest in Voting Shares in Public Companies On 20 April 2006 we were informed by The Capital Group Companies, Inc., aregistered investment manager in the U.S., that on 18 April 2006 its interest inthe USD0.25 Ordinary Shares of AstraZeneca PLC had increased to 202,010,016shares (12.78 per cent of the current issued ordinary capital) from thepreviously notified level of 198,942,168 shares (12.54 per cent of the issuedordinary capital at that time). The reason for this announcement is that,within the said holding of 12.78 per cent of the issued ordinary capital ofAstraZeneca PLC, Capital Research and Management Company, an affiliate of TheCapital Group Companies, Inc., has increased its interest in these shares to95,661,741 shares (6.05 per cent). G H R Musker Company Secretary 20 April 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca